Rheos Capital Works’s Surgery Partners SGRY Stock Holding History

Rheos Capital Works’s Portfolio SGRY Stock Details SGRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-174,000	Closed	-$4.85M	–	142
2022 Q4	$4.85M	Sell	174,000 -762	-0.4%	-$20.2K	0.29%	103
2022 Q3	$4.09M	Hold	174,762	–	–	0.28%	112
2022 Q2	$5.05M	Sell	174,762 -239,238	-58%	-$10.5M	0.38%	98
2022 Q1	$22.8M	Hold	414,000	–	–	1.1%	28
2021 Q4	$22.1M	Hold	414,000	–	–	0.97%	33
2021 Q3	$17.5M	Buy	414,000 +16,000	+4%	+$816K	0.9%	39
2021 Q2	$26.5M	Buy	+398,000	New	+$21.6M	1.34%	15

Other funds holding SGRY

BCI

Bain Capital Investors Boston, Massachusetts $3.27B AUM 3.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Rheos Capital Works's SGRY Position: Q1 2023 in Review

Rheos Capital Works sold out of Surgery Partners (SGRY) in Q1 2023, closing a stake of 174,000 shares — an estimated $4.85M sold.

Rheos Capital Works first reported a position in SGRY in Q2 2021 and held it in 7 quarters. The position peaked at $26.5M in Q2 2021. 151 funds tracked by Wall St. Rank hold SGRY as of Q1 2023.

Rheos Capital Works reported no remaining Surgery Partners position as of Q1 2023 after selling out during the quarter.
Rheos Capital Works sold 174,000 Surgery Partners shares in Q1 2023, an estimated $4.85M.
Rheos Capital Works first reported a position in Surgery Partners in Q2 2021 and held it in 7 quarters.
Rheos Capital Works's Surgery Partners position peaked at $26.5M in Q2 2021.
151 funds tracked by Wall St. Rank held Surgery Partners as of Q1 2023.

Based on Rheos Capital Works's 13F filing for Q1 2023, filed 3 May 2023.